Literature DB >> 1916482

Smoking, humoral immunity, and ulcerative colitis.

E D Srivastava1, J R Barton, S O'Mahony, D I Phillips, G T Williams, N Matthews, A Ferguson, J Rhodes.   

Abstract

Since ulcerative colitis predominantly affects non-smokers and ex-smokers we have examined the possibility that smoking modifies the humoral immune response to an antigenic challenge from the gut lumen. Gut lavage was used in healthy subjects and patients with ulcerative colitis, including both smokers and non-smokers. Antibodies in the intestinal fluid to Escherichia coli (five pooled serotypes), Candida albicans, gliadin, ovalbumin, and beta lactoglobulin were measured by ELISA to determine specific antibody concentrations of IgG, IgA, and IgM classes. Total IgG, IgA, and IgM were also measured in intestinal secretions and serum. In addition, circulating antibody concentrations of IgG, IgA, and IgM to three gut commensals - E coli (five pooled serotypes) C albicans, and Poroteus mirabilis were measured. There was a significant reduction in the IgA concentration in intestinal fluid of smokers with ulcerative colitis compared with healthy non-smoking controls. No other significant differences were found between the groups. Overall, these data are not consistent with the idea that smoking suppresses immune responses in the gut and suggest that the effect of smoking in colitis is mediated by another mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916482      PMCID: PMC1379041          DOI: 10.1136/gut.32.9.1016

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers.

Authors:  E D Srivastava; M B Hallett; J Rhodes
Journal:  Hum Toxicol       Date:  1989-11

2.  Smoking and colonic mucus in ulcerative colitis.

Authors:  G F Cope; R V Heatley; J K Kelleher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Association of cigarette smoking with decreased numbers of circulating natural killer cells.

Authors:  D J Tollerud; J W Clark; L M Brown; C Y Neuland; D L Mann; L K Pankiw-Trost; W A Blattner; R N Hoover
Journal:  Am Rev Respir Dis       Date:  1989-01

4.  Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers.

Authors:  Y Cormier; J Bélanger; P Durand
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

5.  Measurement of antibodies to Candida albicans as a screening test for humoral immunodeficiency.

Authors:  D I Phillips; N Matthews
Journal:  J Immunol Methods       Date:  1987-12-04       Impact factor: 2.303

Review 6.  Cigarette smoking and respiratory tract infection.

Authors:  T W Marcy; W W Merrill
Journal:  Clin Chest Med       Date:  1987-09       Impact factor: 2.878

7.  Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro.

Authors:  M Laviolette; R Coulombe; S Picard; P Braquet; P Borgeat
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Does smoking tighten the gut?

Authors:  H Prytz; C Benoni; C Tagesson
Journal:  Scand J Gastroenterol       Date:  1989-11       Impact factor: 2.423

9.  A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.

Authors:  M M Gaspari; P T Brennan; S M Solomon; C O Elson
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

10.  Late presentation of ulcerative colitis in ex-smokers.

Authors:  R J Motley; J Rhodes; S Kay; T J Morris
Journal:  Int J Colorectal Dis       Date:  1988-08       Impact factor: 2.571

View more
  13 in total

Review 1.  Role of smoking in inflammatory bowel disease: implications for therapy.

Authors:  G A Thomas; J Rhodes; J T Green; C Richardson
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

Review 2.  Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Authors:  Martin H Holtmann; Peter R Galle
Journal:  Langenbecks Arch Surg       Date:  2004-02-04       Impact factor: 3.445

3.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

4.  Adult coeliac disease and cigarette smoking.

Authors:  J A Snook; L Dwyer; C Lee-Elliott; S Khan; D W Wheeler; D S Nicholas
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

Review 5.  The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis.

Authors:  J Birtwistle
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 6.  Ulcerative colitis in smokers, non-smokers and ex-smokers.

Authors:  Guillermo Bastida; Belén Beltrán
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 7.  Nicotine treatment in ulcerative colitis. Current status.

Authors:  J Rhodes; G Thomas
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

8.  Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.

Authors:  S A Mitchell; M Thyssen; T R Orchard; D P Jewell; K A Fleming; R W Chapman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Smoking and ulcerative colitis: a community study.

Authors:  E D Srivasta; R G Newcombe; J Rhodes; P Avramidis; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

10.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.